S H Kelkar & Company Ltd
SHK NSE
S H Kelkar & Company Ltd
ChemicalsNSE: SHK BSE: 539450 Specialty Chemicals
Key Fundamentals
MicrocapSpecialty ChemicalsChemicalsMarket Cap
₹2,371 Cr
Volatility
High Risk
P/E Ratio
26.86
EBITDA
₹251 Cr
Return on Equity
5.08%
Debt to Equity
0.76
Book Value
₹98.39
EPS
₹8.23
52W High
₹275.5
52W Low
₹111.98
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view S H Kelkar & Company Ltd insights
58 extracted metrics + investor summaries across FY12–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company's working capital requirements have reduced from 53.1 days to 38.0 days
Weaknesses
4- Company has a low return on equity of 7.23% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.74.1 Cr.
- Promoter holding has decreased over last 3 years: -4.08%
Growth Rate
Revenue Growth
10.74% ↗
Net Income Growth
-6.61% ↘
Cash Flow Change
1571.73% ↗
ROE
-12.71% ↘
ROCE
-9.46% ↘
EBITDA Margin (Avg.)
-29.25% ↘
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 423 | 455 | 472 | 513 | 470 | 542 | 543 | 567 | 580 | 554 | 584 | 650 | 662 |
| Expenses | 355 | 384 | 396 | 424 | 392 | 462 | 480 | 494 | 507 | 502 | 528 | 589 | 575 |
| Operating Profit | 68 | 72 | 76 | 90 | 78 | 80 | 64 | 73 | 73 | 52 | 55 | 61 | 88 |
| OPM % | 16% | 16% | 16% | 17% | 17% | 15% | 12% | 13% | 13% | 9% | 9% | 9% | 13% |
| Other Income | 2 | 2 | 2 | 0 | -120 | 21 | 1 | 61 | 3 | 1 | 34 | 7 | 31 |
| Interest | 10 | 10 | 10 | 10 | 10 | 13 | 14 | 13 | 13 | 14 | 14 | 15 | 15 |
| Depreciation | 21 | 22 | 22 | 22 | 22 | 24 | 23 | 25 | 26 | 27 | 27 | 39 | 35 |
| PBT | 39 | 41 | 46 | 57 | -74 | 64 | 27 | 97 | 37 | 12 | 49 | 15 | 69 |
| Tax % | 28% | 27% | 30% | 42% | 17% | 38% | 36% | -6% | 30% | 25% | 33% | 88% | 34% |
| Net Profit | 28 | 30 | 32 | 33 | -87 | 40 | 18 | 103 | 26 | 9 | 33 | 2 | 45 |
| EPS in Rs | 1.96 | 2.12 | 2.33 | 2.45 | -6.25 | 2.87 | 1.27 | 7.41 | 1.85 | 0.66 | 2.36 | 0.13 | 3.28 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 834 | 925 | 981 | 1,021 | 1,048 | 1,114 | 1,322 | 1,564 | 1,687 | 1,930 | 2,123 | 2,368 | 2,450 |
| Expenses | 716 | 774 | 814 | 862 | 908 | 955 | 1,083 | 1,350 | 1,469 | 1,622 | 1,828 | 2,126 | 2,193 |
| Operating Profit | 119 | 151 | 167 | 159 | 141 | 160 | 239 | 215 | 217 | 308 | 296 | 242 | 256 |
| OPM % | 14% | 16% | 17% | 16% | 13% | 14% | 18% | 14% | 13% | 16% | 14% | 10% | 10% |
| Other Income | 25 | 10 | 12 | 13 | 21 | -28 | 36 | 6 | -8 | 5 | -38 | 45 | 74 |
| Interest | 19 | 22 | 6 | 5 | 16 | 26 | 20 | 16 | 24 | 41 | 49 | 56 | 57 |
| Depreciation | 29 | 30 | 19 | 24 | 31 | 52 | 62 | 72 | 80 | 89 | 95 | 119 | 128 |
| PBT | 94 | 110 | 153 | 143 | 115 | 54 | 194 | 132 | 104 | 182 | 114 | 112 | 145 |
| Tax % | 26% | 34% | 31% | 35% | 24% | 34% | 26% | -13% | 40% | 32% | 36% | 38% | — |
| Net Profit | 70 | 73 | 105 | 94 | 88 | 36 | 144 | 149 | 63 | 124 | 73 | 69 | 89 |
| EPS in Rs | 5.32 | 5.05 | 7.25 | 6.49 | 6.12 | 2.53 | 10.24 | 10.73 | 4.42 | 8.84 | 5.29 | 5 | 6.43 |
| Div. Payout % | 28% | 30% | 24% | 27% | 0% | 38% | 17% | 7% | 45% | 8% | 19% | 20% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 | 138 | 138 |
| Reserves | 368 | 571 | 667 | 712 | 719 | 683 | 810 | 875 | 926 | 1,074 | 1,134 | 1,223 |
| Borrowings | 252 | 85 | 74 | 172 | 342 | 365 | 518 | 698 | 620 | 666 | 832 | 1,029 |
| Other Liabilities | 187 | 201 | 187 | 246 | 222 | 277 | 405 | 568 | 518 | 502 | 556 | 493 |
| Total Liabilities | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,884 |
| Fixed Assets | 274 | 227 | 296 | 352 | 462 | 472 | 741 | 959 | 914 | 933 | 953 | 1,182 |
| CWIP | 10 | 18 | 7 | 60 | 38 | 18 | 28 | 9 | 26 | 13 | 46 | 96 |
| Investments | 0 | 35 | 50 | 96 | 97 | 97 | 1 | 1 | 23 | 10 | 11 | 11 |
| Other Assets | 655 | 722 | 720 | 767 | 830 | 879 | 1,103 | 1,309 | 1,239 | 1,425 | 1,650 | 1,594 |
| Total Assets | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,884 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 62 | 86 | 102 | 103 | 77 | 205 | 195 | 50 | 197 | 107 | 16 | 263 |
| Investing | -17 | -77 | -103 | -162 | -138 | -42 | -148 | -134 | -110 | -84 | -69 | -209 |
| Financing | -7 | -24 | -16 | 28 | 49 | -196 | 88 | 12 | -175 | 8 | 99 | -158 |
| Net Cash Flow | 37 | -14 | -17 | -31 | -12 | -33 | 135 | -71 | -88 | 32 | 46 | -104 |
| Free Cash Flow | 40 | 63 | 64 | -17 | -39 | 161 | 165 | 52 | 149 | 47 | -80 | 60 |
| CFO/OP | 76 | 84 | 89 | 87 | 81 | 146 | 87 | 52 | 109 | 54 | 24 | 135 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 90 | 81 | 99 | 99 | 104 | 103 | 108 | 95 | 93 | 87 | 98 |
| Inventory Days | 252 | 239 | 247 | 233 | 239 | 201 | 216 | 225 | 228 | 231 | 227 | 182 |
| Days Payable | 76 | 116 | 78 | 104 | 86 | 103 | 125 | 143 | 138 | 125 | 127 | 91 |
| Cash Conversion Cycle | 261 | 213 | 250 | 228 | 252 | 202 | 195 | 190 | 185 | 199 | 188 | 189 |
| Working Capital Days | 70 | 135 | 128 | 110 | 86 | 55 | 91 | 90 | 88 | 60 | 62 | 38 |
| ROCE % | 14% | 17% | 19% | 17% | 12% | 10% | 15% | 10% | 8% | 12% | 10% | 6% |
Documents
1
Board Meeting Intimation for Consideration Of Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31, 2026
16h - Board meeting on May 15, 2026 to approve audited Q4 and FY26 results; trading window closed till May 17. 16h - Board meeting on May 15, 2026 to approve audited Q4 and FY26 results; trading window closed till May 17.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Quarter ended March 31, 2026 Regulation 74(5) certificate confirms all securities held in demat form. 8 Apr - Quarter ended March 31, 2026 Regulation 74(5) certificate confirms all securities held in demat form.
4
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
6 Apr - FY2026-27 initial disclosure says SH Kelkar is not a large corporate; outstanding borrowing Rs 222.70 crore. 6 Apr - FY2026-27 initial disclosure says SH Kelkar is not a large corporate; outstanding borrowing Rs 222.70 crore.
5
Business Update For Q4 FY 2025-26
3 Apr - Q4 FY2025-26 update: FY26 consolidated revenue rose 11.5% to Rs.2,355 crore; net debt Rs.789 crore. 3 Apr - Q4 FY2025-26 update: FY26 consolidated revenue rose 11.5% to Rs.2,355 crore; net debt Rs.789 crore.
Frequently Asked Questions about S H Kelkar & Company Ltd
What does S H Kelkar & Company Ltd do?
S H Kelkar and Company Limited is engaged in manufacture, supply and exports of fragrances and aroma ingredients[1] It is the largest domestic fragrance producer in India and the only company of Indian origin to file patents in the field of Fragrance & Novel aroma molecules.
Where is S H Kelkar & Company Ltd (SHK) listed?
S H Kelkar & Company Ltd is listed on the Indian stock exchanges. It is listed on NSE: SHK and BSE: 539450. You can view its live share price, financials, and ratios on Tapetide.
Which sector does S H Kelkar & Company Ltd belong to?
S H Kelkar & Company Ltd operates in the Chemicals sector within the Specialty Chemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of S H Kelkar & Company Ltd?
S H Kelkar & Company Ltd has a market capitalisation of approximately ₹2370.59 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of S H Kelkar & Company Ltd?
The Price-to-Earnings (PE) ratio of S H Kelkar & Company Ltd is 26.86. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of S H Kelkar & Company Ltd?
Over the past 52 weeks, S H Kelkar & Company Ltd has traded between a low of ₹111.98 and a high of ₹275.5. This range helps investors understand the stock's price volatility and recent trading levels.
Does S H Kelkar & Company Ltd pay dividends?
Yes, S H Kelkar & Company Ltd has a dividend yield of 0.59%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of S H Kelkar & Company Ltd?
S H Kelkar & Company Ltd has a Return on Equity (ROE) of 5.08%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research S H Kelkar & Company Ltd on Tapetide?
On Tapetide, you can view S H Kelkar & Company Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
S H Kelkar and Company Limited is engaged in manufacture, supply and exports of fragrances and aroma ingredients[1] It is the largest domestic fragrance producer in India and the only company of Indian origin to file patents in the field of Fragrance & Novel aroma molecules.
Website keva.co.in
CEO Mr. Kedar Ramesh Vaze
Employees 635
Listed 2015-11-16
Face Value ₹ 10
Issued Size 13,84,20,801